Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Endocrinology ; 146(7): 3070-9, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15817665

ABSTRACT

Estradiol at physiological concentrations intervenes in apoptotic death cascades and ameliorates neuronal death in experimental models of focal and global ischemia. The cellular targets that mediate estradiol protection of hippocampal neurons in global ischemia are, however, unclear. The present study examined the hypothesis that estradiol protects hippocampal neurons in ovariectomized rats via estrogen receptor (ER)alpha and/or beta. Estradiol (14 d pretreatment) afforded robust protection of CA1 neurons against global ischemia-induced death. The broad-spectrum ER antagonist ICI 182,780 (intracerebroventricularly, 0 and 12 h after ischemia) abolished estrogen protection, consistent with a role for ERs. To evaluate the potential roles of ERalpha vs. ERbeta in estrogen protection, we administered subtype-selective agonists for 14 d before and 7 d after ischemia. The ERalpha-selective agonist propyl pyrazole triol (PPT, 10 mg/kg) and ERbeta-selective agonist WAY 200070-3 (1 mg/kg) produced nearly complete protection of CA1 neurons in approximately 50% of the animals. PPT, but not WAY 200070-3, at doses used for protection, elicited lordosis, induced negative feedback inhibition of LH release, and reduced weight gain. These findings establish the efficacy of the PPT dose in neuroendocrine assays and specificity of WAY 200070-3 for ERbeta. We also examined the ability of estradiol and neuronal injury to regulate ERalpha and ERbeta expression. Both estradiol and global ischemia markedly increased ERalpha, but not ERbeta, protein in CA1. These data indicate that estradiol can act via ERalpha and ERbeta to protect CA1 neurons from global ischemia-induced death and that both estradiol and global ischemia modulate ERalpha expression in hippocampal CA1.


Subject(s)
Brain Ischemia/physiopathology , Estradiol/pharmacology , Estrogen Receptor alpha/physiology , Estrogen Receptor beta/physiology , Hippocampus/physiopathology , Neuroprotective Agents/pharmacology , Animals , Brain Ischemia/pathology , Cell Survival/drug effects , Cell Survival/physiology , Dose-Response Relationship, Drug , Estrogen Receptor alpha/agonists , Estrogen Receptor beta/agonists , Feedback, Physiological , Female , Hippocampus/drug effects , Hippocampus/pathology , Lordosis/chemically induced , Luteinizing Hormone/antagonists & inhibitors , Neurons/drug effects , Neurons/pathology , Neuroprotective Agents/administration & dosage , Oxazoles/administration & dosage , Oxazoles/pharmacology , Phenols/administration & dosage , Phenols/pharmacology , Pyrazoles/administration & dosage , Pyrazoles/pharmacology , Rats , Rats, Sprague-Dawley , Time Factors , Weight Gain/drug effects
2.
J Neurosci ; 24(44): 9903-13, 2004 Nov 03.
Article in English | MEDLINE | ID: mdl-15525775

ABSTRACT

Transient global ischemia induces a delayed rise in intracellular Zn2+, which may be mediated via glutamate receptor 2 (GluR2)-lacking AMPA receptors (AMPARs), and selective, delayed death of hippocampal CA1 neurons. The molecular mechanisms underlying Zn2+ toxicity in vivo are not well delineated. Here we show the striking finding that intraventricular injection of the high-affinity Zn2+ chelator calcium EDTA (CaEDTA) at 30 min before ischemia (early CaEDTA) or at 48-60 hr (late CaEDTA), but not 3-6 hr, after ischemia, afforded robust protection of CA1 neurons in approximately 50% (late CaEDTA) to 75% (early CaEDTA) of animals. We also show that Zn2+ acts via temporally distinct mechanisms to promote neuronal death. Early CaEDTA attenuated ischemia-induced GluR2 mRNA and protein downregulation (and, by inference, formation of Zn2+-permeable AMPARs), the delayed rise in Zn2+, and neuronal death. These findings suggest that Zn2+ acts at step(s) upstream from GluR2 gene downregulation and implicate Zn2+ in transcriptional regulation and/or GluR2 mRNA stability. Early CaEDTA also blocked mitochondrial release of cytochrome c and Smac/DIABLO (second mitochondria-derived activator of caspases/direct inhibitor of apoptosis protein-binding protein with low pI), caspase-3 activity (but not procaspase-3 cleavage), p75NTR induction, and DNA fragmentation. These findings indicate that CaEDTA preserves the functional integrity of the mitochondrial outer membrane and arrests the caspase death cascade. Late injection of CaEDTA at a time when GluR2 is downregulated and caspase is activated inhibited the delayed rise in Zn2+, p75NTR induction, DNA fragmentation, and cell death. The finding of neuroprotection by late CaEDTA administration has striking implications for intervention in the delayed neuronal death associated with global ischemia.


Subject(s)
Brain Ischemia/pathology , Chelating Agents/pharmacology , Edetic Acid/pharmacology , Hippocampus/pathology , Neurons/pathology , Zinc/physiology , Animals , Apoptosis Regulatory Proteins , Brain Ischemia/metabolism , Carrier Proteins/metabolism , Caspase 3 , Caspases/metabolism , Cell Death/drug effects , Cell Death/physiology , Cytochromes c/metabolism , DNA Fragmentation/drug effects , Gerbillinae , Hippocampus/drug effects , Hippocampus/metabolism , Male , Mitochondria/metabolism , Mitochondrial Proteins/metabolism , Neurons/drug effects , Neurons/metabolism , Rats , Rats, Sprague-Dawley , Receptor, Nerve Growth Factor , Receptors, AMPA/metabolism , Receptors, AMPA/physiology , Receptors, Nerve Growth Factor/metabolism , Time Factors , Zinc/metabolism
3.
J Neurosci ; 24(11): 2750-9, 2004 Mar 17.
Article in English | MEDLINE | ID: mdl-15028768

ABSTRACT

Apoptosis is an evolutionarily conserved process critical to tissue development and tissue homeostasis in eukaryotic organisms and, when dysregulated, causes inappropriate cell death. Global ischemia is a neuronal insult that induces delayed cell death with many features of apoptosis. Ischemic preconditioning affords robust protection of CA1 neurons against a subsequent severe ischemic challenge. The molecular mechanisms underlying ischemic tolerance are unclear. Here we show that ischemia induces pronounced caspase-3 activity in naive neurons that die and in preconditioned neurons that survive. Preconditioning intervenes downstream of proteolytic processing and activation of caspase-3 (a protease implicated in the execution of apoptosis) and upstream of the caspase-3 target caspase-activated DNase (CAD, a deoxyribonuclease that catalyzes DNA fragmentation) to arrest neuronal death. We further show that global ischemia promotes expression of the pro-survival inhibitor-of-apoptosis (IAP) family member cIAP, but unleashes Smac/DIABLO (second mitochondria-derived activator of caspases/direct IAP-binding protein with low pI), a factor that neutralizes the protective actions of IAPs and promotes neuronal death. Preconditioning blocks the mitochondrial release of Smac/DIABLO, but not the ischemia-induced upregulation of IAPs. In the absence of Smac/DIABLO, cIAP halts the caspase death cascade and arrests neuronal death. These findings suggest that preconditioning preserves the integrity of the mitochondrial membrane, enabling neurons to survive in the face of caspase activation.


Subject(s)
Brain Ischemia/physiopathology , Caspases/metabolism , Ischemic Preconditioning , Neurons/metabolism , Animals , Apoptosis Regulatory Proteins , Blotting, Western , Brain Ischemia/enzymology , Carrier Proteins/metabolism , Caspase 3 , Caspase 9 , Cell Survival/physiology , Cytoprotection/physiology , DNA Fragmentation , Deoxyribonucleases/metabolism , Disease Models, Animal , Enzyme Activation/physiology , HSP70 Heat-Shock Proteins/metabolism , In Situ Nick-End Labeling , Inhibitor of Apoptosis Proteins , Male , Mitochondrial Proteins/metabolism , Neurons/enzymology , Proteins/metabolism , Rats , Rats, Sprague-Dawley , Receptor, Nerve Growth Factor , Receptors, Nerve Growth Factor/metabolism , Up-Regulation
4.
J Neurosci ; 23(6): 2112-21, 2003 Mar 15.
Article in English | MEDLINE | ID: mdl-12657670

ABSTRACT

A subset of genes implicated in genetic and acquired neurological disorders encode proteins essential to neural patterning and neurogenesis. The gene silencing transcription factor neuronal repressor element-1 silencing transcription factor (REST)/neuron-restrictive silencer factor (NRSF) plays a critical role in elaboration of the neuronal phenotype. In neural progenitor and non-neural cells, REST acts by repression of a subset of neural genes important to synaptic plasticity and synaptic remodeling, including the AMPA receptor (AMPAR) subunit GluR2. Here we show that global ischemia triggers REST mRNA and protein expression. REST suppresses GluR2 promoter activity and gene expression in neurons destined to die. Because the GluR2 subunit governs AMPAR Ca2+ permeability, these changes are expected to have profound effects on neuronal survival. In keeping with this concept, acute knockdown of the REST gene by antisense administration prevents GluR2 suppression and rescues post-ischemic neurons from ischemia-induced cell death in an in vitro model. To our knowledge, our study represents the first example of ischemia-induced induction of a master transcriptional regulator gene and its protein expression critical to neural differentiation and patterning in adult neurons. Derepression of REST is likely to be an important mechanism of insult-induced neuronal death.


Subject(s)
Brain Ischemia/metabolism , Neurons/metabolism , Repressor Proteins/metabolism , Transcription Factors/metabolism , Animals , Brain Ischemia/pathology , Cell Death/physiology , Cell Nucleus/metabolism , Cytoplasm/metabolism , Disease Models, Animal , Hippocampus/blood supply , Hippocampus/metabolism , Hippocampus/pathology , In Vitro Techniques , Ischemic Preconditioning , Male , Neurons/drug effects , Neurons/pathology , Oligonucleotides, Antisense/pharmacology , Promoter Regions, Genetic , Pyramidal Cells/drug effects , Pyramidal Cells/metabolism , Pyramidal Cells/pathology , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, AMPA/genetics , Receptors, AMPA/metabolism , Repressor Proteins/antagonists & inhibitors , Repressor Proteins/genetics , Transcription Factors/antagonists & inhibitors , Transcription Factors/genetics
5.
J Neurosci ; 22(6): 2115-24, 2002 Mar 15.
Article in English | MEDLINE | ID: mdl-11896151

ABSTRACT

The importance of postmenopausal estrogen replacement therapy in affording protection against the selective and delayed neuronal death associated with cardiac arrest or cardiac surgery in women remains controversial. Here we report that exogenous estrogen at levels that are physiological for hormone replacement in postmenopausal women affords protection against global ischemia-induced neuronal death and prevents activation of apoptotic signaling cascades in the hippocampal CA1 of male gerbils. Global ischemia induced a marked increase in activated caspase-3 in CA1, evident at 6 hr after ischemia. Global ischemia induced a marked upregulation of the proapoptotic neurotrophin receptor p75(NTR) in CA1, evident at 48 hr. p75(NTR) expression was induced primarily in terminal deoxynucleotidyl transferase-mediated UTP nick-end labeling-positive cells, indicating expression in neurons undergoing apoptosis. Global ischemia also induced a marked downregulation of mRNA encoding the AMPA receptor GluR2 subunit in CA1. Caspase-3, p75(NTR), and GluR2 were not significantly changed in CA3 and dentate gyrus, indicating that the ischemia-induced changes in gene expression were cell specific. Exogenous estrogen attenuated the ischemia-induced increases in activated caspase-3 and blocked the increase in p75(NTR) in post-ischemic CA1 neurons but did not prevent ischemia-induced downregulation of GluR2. These findings demonstrate that long-term estrogen at physiological levels ameliorates ischemia-induced hippocampal injury and indicate that estrogen intervenes at the level of apoptotic signaling cascades to prevent onset of death in neurons otherwise "destined to die."


Subject(s)
Brain Ischemia/drug therapy , Estrogens/administration & dosage , Hippocampus/drug effects , Neurons/drug effects , Signal Transduction/drug effects , Animals , Apoptosis/drug effects , Blotting, Western , Brain Ischemia/pathology , Caspase 3 , Caspases/metabolism , Cytoprotection/drug effects , Down-Regulation , Enzyme Activation/drug effects , Gerbillinae , Glutamate Decarboxylase , Hippocampus/blood supply , Hippocampus/pathology , In Situ Hybridization , Male , Neurons/enzymology , Neurons/pathology , RNA, Messenger/metabolism , Receptor, Nerve Growth Factor , Receptors, AMPA/genetics , Receptors, AMPA/metabolism , Receptors, Nerve Growth Factor/metabolism , Up-Regulation/drug effects
6.
Proc Natl Acad Sci U S A ; 99(4): 2362-7, 2002 Feb 19.
Article in English | MEDLINE | ID: mdl-11842229

ABSTRACT

Animals subjected to sublethal transient global ischemia (ischemic preconditioning) exhibit neuroprotection against subsequent global ischemia-induced neuronal death in the hippocampal CA1 (ischemic tolerance). The molecular mechanisms underlying ischemic tolerance are unclear. Here we report that ischemic preconditioning induced a small, transient down-regulation of GluR2 mRNA expression and greatly attenuated subsequent ischemia-induced GluR2 mRNA and protein down-regulation and neuronal death. Ischemic preconditioning and GluR2 antisense knockdown acted synergistically to increase cell death. Sublethal antisense knockdown did not protect against subsequent ischemic insults or antisense knockdown. These findings indicate that ischemic preconditioning acts at step(s) upstream from suppression of GluR2 gene expression to afford neuroprotection and implicate transcriptional regulation of GluR2 expression in the adaptive mechanisms associated with ischemic tolerance.


Subject(s)
Down-Regulation , Hippocampus/metabolism , Hippocampus/pathology , Ischemic Preconditioning , Neurons/metabolism , Receptors, AMPA/biosynthesis , Animals , Blotting, Western , Calcium/metabolism , Cell Death , DNA, Complementary/metabolism , Gerbillinae , In Situ Hybridization , Ischemia , Male , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Glutamate/metabolism , Time Factors
7.
J Food Prot ; 60(7): 825-830, 1997 Jul.
Article in English | MEDLINE | ID: mdl-31026879

ABSTRACT

Changes in biogenic amines, pH, water activity values. and counts of aerobic, lactic acid, Enterobacteriaceae , and pseudomonad bacteria were followed during production of dry sausage. The effect of two starter cultures, Lactobacillus plantarum plus Micrococcus carnosus and Pediococcus pentosaceus plus Micrococcus carnosus , on amine production was investigated. Raw materials used in sausage production only contributed spermine and spermidine to the final products. Tyramine, putrescine, and cadaverine contents increased during the fermentation stage, and tyramine was the prevailing amine in the final sausages. Sausages produced by fermentation with starters, as compared to natural fermentation (control), had a lower amount of tyramine, putrescine, and cadaver-ine' but differences in microbial counts were minor. Levels of spermine decreased during sausage production and those of spermidine remained relatively constant. Aerobic plate and lactic acid bacteria counts increased during ripening while levels of species of Enterobacteriaceae and pseudomonads decreased. Starters seemed to decrease the biogenic amine formation but did not prevent it. The high background flora naturally present on the starting meat and pork lard seemed to have a strong influence on biogenic amine formation during ripening.

SELECTION OF CITATIONS
SEARCH DETAIL
...